Elisavet Georgiou
Overview
Explore the profile of Elisavet Georgiou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolanis S, Kotanidou E, Tsinopoulou V, Georgiou E, Hatzipantelis E, Fidani L, et al.
Children (Basel)
. 2025 Jan;
12(1).
PMID: 39857939
gene polymorphisms (677C>T and 1298A>C) correlate with various types of cancer across all age groups; however, a small number of studies have included solely children and adolescents. The aim of...
2.
Nikolaou V, Koumprentziotis I, Papadavid E, Patsatsi A, Diavati S, Tsimpidakis A, et al.
Int J Dermatol
. 2024 Nov;
PMID: 39526550
Background: Primary cutaneous B-cell lymphomas (PCBCLs) are rare cutaneous neoplasms with limited literature regarding treatment options and associated treatment outcomes. This study aimed to investigate and present real-world treatment outcomes...
3.
Nikolaou V, Panou E, Tsimpidakis A, Koumprentziotis I, Patsatsi A, Siakantaris M, et al.
J Eur Acad Dermatol Venereol
. 2024 Sep;
PMID: 39297278
Background: Methotrexate (MTX) has been a longstanding therapeutic option for mycosis fungoides (MF); however, data on its real-world effectiveness remain limited. Objectives: To evaluate treatment-related outcomes of oral MTX in...
4.
Ioannidou M, Avgeros C, Georgiou E, Papadimitriou-Tsantarliotou A, Dimitriadis D, Tragiannidis A, et al.
Int J Hematol
. 2024 Mar;
119(6):755-761.
PMID: 38507115
Background: Medications used to treat acute lymphoblastic leukemia (ALL), such as L-asparaginase, can cause blood lipid disturbances. These can also be associated with polymorphisms of the lipoprotein lipase (LpL) and...
5.
Tsotridou E, Georgiou E, Tragiannidis A, Avgeros C, Tzimagiorgis G, Lambrou M, et al.
Oncol Lett
. 2024 Jan;
27(2):71.
PMID: 38192661
MicroRNAs (miRNAs/miRs) are promising prognostic biomarkers in pediatric acute lymphoblastic leukemia (ALL). The present study aimed to identify miRNAs that could serve as prognostic biomarkers or as novel therapeutic targets...
6.
Syrnioti A, Georgiou E, Patsatsi A, Dimitriadis D, Papathemeli D, Koletsa T
Cureus
. 2023 Oct;
15(9):e46085.
PMID: 37900389
Background: Emerging data indicate that the cellular microenvironment and interleukins (IL) play a crucial role in mycosis fungoides (MF). We aimed to explore the potential association between the composition of...
7.
Georgiou E, Nikolaou V, Pikou O, Papathemeli D, Haidich A, Koletsa T, et al.
Eur J Dermatol
. 2023 Oct;
33(4):433-435.
PMID: 37823498
No abstract available.
8.
Avgeros C, Patsatsi A, Dimitriadis D, Malousi A, Koletsa T, Papathemeli D, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613718
Diagnosis of Mycosis Fungoides (MF) may be challenging, due to its polymorphic nature. The use of miRNAs as biomarkers to assist in diagnosis has been investigated, mainly in skin lesion...
9.
Sofou E, Zaragoza-Infante L, Pechlivanis N, Karakatsoulis G, Notopoulou S, Stavroyianni N, et al.
Front Oncol
. 2023 Jan;
12:1079772.
PMID: 36591518
Classification of patients with chronic lymphocytic leukemia (CLL) based on the somatic hypermutation (SHM) status of the clonotypic immunoglobulin heavy variable (IGHV) gene has established predictive and prognostic relevance. The...
10.
Syrnioti A, Patsatsi A, Georgiou E, Avgeros C, Koletsa T
Acta Derm Venereol
. 2022 Mar;
102:adv00701.
PMID: 35356996
No abstract available.